Shares of Align Technology, Inc. (NASDAQ:ALGN) have received a consensus recommendation of “Buy” from the eleven brokerages that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $188.33.

A number of brokerages recently commented on ALGN. Stifel Nicolaus restated a “buy” rating and issued a $205.00 price objective (up previously from $200.00) on shares of Align Technology in a research report on Monday, August 7th. Robert W. Baird restated a “buy” rating on shares of Align Technology in a research report on Tuesday. Goldman Sachs Group, Inc. (The) raised their price objective on shares of Align Technology to $210.00 and gave the company a “buy” rating in a research report on Friday. Piper Jaffray Companies restated a “buy” rating and issued a $200.00 price objective on shares of Align Technology in a research report on Monday, September 11th. Finally, Bank of America Corporation upgraded shares of Align Technology from a “neutral” rating to a “buy” rating and raised their price objective for the company from $175.00 to $193.00 in a research report on Friday, July 28th.

Align Technology (NASDAQ ALGN) opened at 184.50 on Friday. The company has a 50 day moving average price of $175.22 and a 200 day moving average price of $143.46. The stock has a market cap of $14.79 billion, a price-to-earnings ratio of 63.18 and a beta of 1.55. Align Technology has a 52 week low of $83.27 and a 52 week high of $186.10.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $0.85 EPS for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.12. The firm had revenue of $356.50 million during the quarter, compared to the consensus estimate of $343.43 million. Align Technology had a net margin of 19.18% and a return on equity of 23.87%. The firm’s revenue was up 32.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.62 earnings per share. Analysts expect that Align Technology will post $3.40 EPS for the current fiscal year.

Institutional investors have recently modified their holdings of the business. CENTRAL TRUST Co increased its holdings in Align Technology by 128.5% in the second quarter. CENTRAL TRUST Co now owns 697 shares of the medical equipment provider’s stock valued at $105,000 after buying an additional 392 shares in the last quarter. Schroder Investment Management Group purchased a new position in Align Technology in the second quarter valued at about $104,000. Bronfman E.L. Rothschild L.P. increased its holdings in Align Technology by 13.0% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 912 shares of the medical equipment provider’s stock valued at $137,000 after buying an additional 105 shares in the last quarter. BlueMountain Capital Management LLC purchased a new position in Align Technology in the second quarter valued at about $148,000. Finally, Trust Co. of Vermont increased its holdings in Align Technology by 15.4% in the second quarter. Trust Co. of Vermont now owns 1,010 shares of the medical equipment provider’s stock valued at $152,000 after buying an additional 135 shares in the last quarter. 81.72% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Align Technology, Inc. (ALGN) Given Average Rating of “Buy” by Brokerages” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.americanbankingnews.com/2017/09/16/align-technology-inc-algn-given-average-rating-of-buy-by-brokerages.html.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Analyst Recommendations for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.